- Home
- INAB vs AEON Comparison
INAB vs AEON Comparison
Compare INAB & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INAB
- AEON
- Stock Information
- Founded
- INAB 2016
- AEON N/A
- Country
- INAB United States
- AEON United States
- Employees
- INAB N/A
- AEON N/A
- Industry
- INAB Biotechnology: Pharmaceutical Preparations
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- INAB Health Care
- AEON Health Care
- Exchange
- INAB Nasdaq
- AEON Nasdaq
- Market Cap
- INAB 9.1M
- AEON 8.0M
- IPO Year
- INAB 2021
- AEON N/A
- Fundamental
- Price
- INAB $2.00
- AEON $0.75
- Analyst Decision
- INAB Strong Buy
- AEON Strong Buy
- Analyst Count
- INAB 2
- AEON 1
- Target Price
- INAB $108.00
- AEON $360.00
- AVG Volume (30 Days)
- INAB 45.9K
- AEON 76.5K
- Earning Date
- INAB 11-11-2025
- AEON 11-12-2025
- Dividend Yield
- INAB N/A
- AEON N/A
- EPS Growth
- INAB N/A
- AEON N/A
- EPS
- INAB N/A
- AEON N/A
- Revenue
- INAB N/A
- AEON N/A
- Revenue This Year
- INAB N/A
- AEON N/A
- Revenue Next Year
- INAB N/A
- AEON N/A
- P/E Ratio
- INAB N/A
- AEON N/A
- Revenue Growth
- INAB N/A
- AEON N/A
- 52 Week Low
- INAB $1.91
- AEON $0.38
- 52 Week High
- INAB $16.70
- AEON $115.57
- Technical
- Relative Strength Index (RSI)
- INAB 39.35
- AEON 48.61
- Support Level
- INAB $1.91
- AEON $0.73
- Resistance Level
- INAB $2.20
- AEON $0.81
- Average True Range (ATR)
- INAB 0.11
- AEON 0.05
- MACD
- INAB -0.01
- AEON 0.00
- Stochastic Oscillator
- INAB 23.08
- AEON 46.09
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.